Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Marshall

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cancers|August 14, 2025
<i>BCOR</i>, <i>BCORL1</i>, and <i>BCL6</i> Mutations in Pediatric LeukemiasThomas C Fisher-Heath, Aastha Sharma, Mark S Marshall, et al.
Clinical Case Reports|January 9, 2023
Targeted treatment of refractory primitive neuroectodermal tumor arising from an immature teratoma with crizotinib leading to a sustained responseBenjamin M Snyder, Alex H Lion, Amy E Helvie, et al.
Molecular Cancer Therapeutics|April 14, 2005
Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cellsMichele T Yip-Schneider, Harikrishna Nakshatri, Christopher J Sweeney, et al.
Molecular Cancer Therapeutics|July 5, 2015
LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent MechanismsConstance King, H Bruce Diaz, Samuel McNeely, et al.
The Journal of Biological Chemistry|March 17, 2021
Retraction: Interferon-inducible protein 10 and macrophage inflammatory protein-1α inhibit growth factor stimulation of Raf-1 kinase activity and protein synthesis in a human growth factor-dependent hematopoietic cell line. VOLUME 270 (1995) PAGES 21998-22007Susan M Aronica, Charlie Mantel, Rene Gonin, et al.
BMC Neuroscience|June 11, 2003
Insulin signaling inhibits the 5-HT2C receptor in choroid plexus via MAP kinaseJoyce H Hurley, Shengwen Zhang, Leighan S Bye, et al.
JCO Precision Oncology|September 14, 2020
Sustained Complete Response to Palbociclib in a Refractory Pediatric Sarcoma With <i>BCOR</i>-<i>CCNB3</i> Fusion and Germline <i>CDKN2B</i> VariantTimothy F Tramontana, Mark S Marshall, Amy E Helvie, et al.
Cancer Detection and Prevention|September 25, 2002
Cyclo-oxygenase-2 expression in primary cancers of the lung and bladder compared to normal adjacent tissueChristopher J Sweeney, Mark S Marshall, Darlene S Barnard, et al.
Pediatric Blood & Cancer|December 1, 2020
Previously unreported somatic variants in two patients with pleuropulmonary blastoma with metastatic brain recurrenceMichael J Ferguson, Jennifer Ivanovich, Paige Stansell, et al.
The Journal of Cell Biology|July 24, 2003
PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activationJill K Slack-Davis, Scott T Eblen, Maja Zecevic, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cancers|August 14, 2025
<i>BCOR</i>, <i>BCORL1</i>, and <i>BCL6</i> Mutations in Pediatric LeukemiasThomas C Fisher-Heath, Aastha Sharma, Mark S Marshall, et al.
Clinical Case Reports|January 9, 2023
Targeted treatment of refractory primitive neuroectodermal tumor arising from an immature teratoma with crizotinib leading to a sustained responseBenjamin M Snyder, Alex H Lion, Amy E Helvie, et al.
Molecular Cancer Therapeutics|April 14, 2005
Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cellsMichele T Yip-Schneider, Harikrishna Nakshatri, Christopher J Sweeney, et al.
Molecular Cancer Therapeutics|July 5, 2015
LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent MechanismsConstance King, H Bruce Diaz, Samuel McNeely, et al.
The Journal of Biological Chemistry|March 17, 2021
Retraction: Interferon-inducible protein 10 and macrophage inflammatory protein-1α inhibit growth factor stimulation of Raf-1 kinase activity and protein synthesis in a human growth factor-dependent hematopoietic cell line. VOLUME 270 (1995) PAGES 21998-22007Susan M Aronica, Charlie Mantel, Rene Gonin, et al.
BMC Neuroscience|June 11, 2003
Insulin signaling inhibits the 5-HT2C receptor in choroid plexus via MAP kinaseJoyce H Hurley, Shengwen Zhang, Leighan S Bye, et al.
JCO Precision Oncology|September 14, 2020
Sustained Complete Response to Palbociclib in a Refractory Pediatric Sarcoma With <i>BCOR</i>-<i>CCNB3</i> Fusion and Germline <i>CDKN2B</i> VariantTimothy F Tramontana, Mark S Marshall, Amy E Helvie, et al.
Cancer Detection and Prevention|September 25, 2002
Cyclo-oxygenase-2 expression in primary cancers of the lung and bladder compared to normal adjacent tissueChristopher J Sweeney, Mark S Marshall, Darlene S Barnard, et al.
Pediatric Blood & Cancer|December 1, 2020
Previously unreported somatic variants in two patients with pleuropulmonary blastoma with metastatic brain recurrenceMichael J Ferguson, Jennifer Ivanovich, Paige Stansell, et al.
The Journal of Cell Biology|July 24, 2003
PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activationJill K Slack-Davis, Scott T Eblen, Maja Zecevic, et al.
Pageof 2